Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat<sup>&reg;</sup> Soft Mist<sup>&trade;</sup> Inhaler

Richard Hodder; David Price

doi:10.2147/COPD.S3391

open access to scientific and medical research

Average Article Statistics

26 Days

from submission to first editorial decision.

22 Days

from editorial acceptance to publication.

*Business days (Mon-Fri)

37575

Papers Published

Submit Manuscript

Journal Email Alerts

Signup for Alerts

About Dove Press

Open access peer-reviewed scientific and medical journals.

Learn more

Open Access

Dove Medical Press is a member of the OAI.

Learn more

Reprints

Bulk reprints for the pharmaceutical industry.

Learn more

Social Media

Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

Review

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat^® Soft Mist^™ Inhaler

Total article views		Abstract views	HTML views	PDF downloads	Totals
21,305	Dovepress*	21,305	0+	2,435	21,305
21,305	Totals	21,305	0	2,435	21,305
*Since 14 October 2009 +Since July 2016

View citations on Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ Inhaler

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat^® Soft Mist^™ Inhaler